Clinical Trials
59 trialsMONAMI
Assistance Publique - Hôpitaux de Paris
HSV G207 With a Single Radiation Dose in Children With Recurrent High-Grade Glioma
Pediatric Brain Tumor Consortium
NeoSarc
Gustave Roussy, Cancer Campus, Grand Paris
A Phase II Study of Adjuvant Immunotherapy Targeting KRAS G12D, KRAS G12V, or TP53 R175H for Participants With Advanced Gastrointestinal Malignancies
National Institutes of Health Clinical Center (CC)
Study of PG2 Injection for Improving Fatigue in Patients After Palliative Abdominal Surgery for Cancer
PhytoHealth Corporation
DEC-C and Thioguanine for R/R AML
Columbia University
Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT
Washington University School of Medicine
A Phase II Randomized Controlled Trial to Determine the Efficacy of an auGmented reAlity gaMe in pediatrIc caNcer Patients Who Are Opioid Tolerant Users Undergoing Surgery to Reduce Post-operative Opioid Use
M.D. Anderson Cancer Center
68-Ga-FAPI PET Imaging in Malignancy
Stanford University
REPAIR
University Medical Center Groningen
The Effect of Cannabis in Pancreatic Cancer
University of Copenhagen
A Study of Pembrolizumab Added to the Standard First-Line Therapy of Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) for NDMM NTE
Canadian Myeloma Research Group
I-PACE
Centessa Pharmaceuticals plc
Study of STI-3031 in Patients With Selected Relapsed or Refractory Solid Tumors
Sorrento Therapeutics, Inc.
Procrit Versus Placebo to Determine Efficacy in Pre-Operative Major Surgical Oncology Operations
University of Louisville
RALT
Asan Medical Center
PECULIAR
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Avatrombopag for Thrombocytopenia in People With Cancer
Memorial Sloan Kettering Cancer Center
Study of Sodium Bicarbonate in Restoring Blocked Catheters
University Health Network, Toronto
Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.
Lumos Pharma
Dual PD-1 and JAK2 Inhibition in Hematological Malignancies
NYU Langone Health
Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination With Anti-Cancer Agents in Relapsed and Refractory Synovial Sarcoma Expressing New York Esophageal Antigen-1 (NY-ESO-1) and/or LAGE-1a
GlaxoSmithKline
Study of Neoadjuvent Chemotherapy Followed by SBRT in Patients With Resectable and Borderline Resectable Pancreatic Cancer
Indiana University
A Study of Venetoclax Plus Lenalidomide and Dexamethasone for the Treatment of Newly Diagnosed t(11;14)-Positive Multiple Myeloma in Subjects Who Are Ineligible for High-Dose Therapy
AbbVie
Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension
University of Kentucky
PanCAN
Georgetown University
Palifermin in Preventing Oral Mucositis Caused by Chemotherapy and/or Radiation Therapy in Young Patients Undergoing Stem Cell Transplant
Children's Oncology Group
Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway Aberrations
University of California, San Diego
Study of Lenvatinib in Patients With Advanced Cancer and Aberrations in FGF/FGFR Signaling
University of California, San Diego
Histology-Independent Study of Palbociclib in Patients With Advanced Cancer
University of California, San Diego
Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent Renal Cell Carcinoma (RCC)
University of Kansas Medical Center
Lenalidomide and Obinutuzumab for Previously Untreated CLL
University of California, San Diego
RESCUE
University of Sao Paulo
Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma
GlaxoSmithKline
HYPOLAN
The Netherlands Cancer Institute
Determine if Either of 2 Doses of Study Drug Given With a Low-dose of Cyclophosphamide After a Complete or Partial Response to a Platinum-based Second-line Therapy in Women With Recurrent Ovarian Carcinoma Results in a Longer Time to Progression When Compared to the First Time to Progression.
EMD Serono
NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer
University of Kentucky
Study to Test the Benefit and Safety of GM-CT-01 in Combination With 5-FU to Treat Bile Duct and Gall Bladder Cancer
Galectin Therapeutics Inc.
A Study for Subjects Who Are Participating in an Astellas-sponsored ASP8273 Study
Astellas Pharma Inc
Pharmacology Study of Aerosolized Liposomal
University of New Mexico
THOR
Berufsverband Niedergelassener Gynäkologischer Onkologen in Deutschland e.V.
ASPIDIA
Centre Francois Baclesse
Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer
University Hospital of Crete
A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer
Labtec GmbH
Prospective Evaluation of a New Covered Metal Stent for Malignant Lesions of the Esophagus
Weill Medical College of Cornell University
U-CARE:TeenCan
Uppsala University
Pilot Study Comparing Treatment With Dexmedetomidine to Midazolam for Symptom Control in Advanced Cancer Patients
Fraser Health
EVAMP
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Cotinine Feedback as an Intervention to Change Parental/Caregiver Smoking Behavior Around Children With Cancer
University of South Florida
Urinary Biomarker Study With Sulindac and Difluoromethylornithine
Cancer Prevention Pharmaceuticals, Inc.